Heart Failure Often Misdiagnosed as Burnout

Heart failure often goes undiagnosed until it reaches an advanced stage, a dangerous delay that turns a manageable condition into a life-threatening emergency. This diagnostic lag is not merely a matter of oversight—it reflects a fundamental mismatch between how heart failure presents in real-world patients and how it is traditionally taught in medical curricula. Symptoms like persistent fatigue, shortness of breath on exertion, and unexplained weight gain are frequently misattributed to stress, aging, or burnout, particularly in younger or otherwise seemingly healthy individuals. The case of Desiree, featured in a recent Omroep West report, exemplifies this perilous blind spot: her declining stamina and swelling ankles were initially dismissed as occupational exhaustion, delaying critical intervention by months. Such delays are not anecdotal; they are epidemiologically significant, contributing to preventable hospitalizations and premature mortality across diverse populations.

• Key Clinical Takeaways:
• Heart failure is frequently misdiagnosed as burnout or anxiety, especially in women and younger adults, leading to dangerous treatment delays.
• Early detection relies on recognizing subtle, progressive symptoms like exertional dyspnea and unexplained fatigue—not just classic signs like chest pain.
• Timely referral to cardiology specialists and utilize of BNP testing can dramatically improve outcomes, reducing hospitalization risk by up to 40%.

The pathophysiology of heart failure involves a vicious cycle of ventricular dysfunction, neurohormonal activation, and fluid retention that gradually impairs cardiac output. While systolic heart failure (reduced ejection fraction) has well-established diagnostic biomarkers, heart failure with preserved ejection fraction (HFpEF)—now accounting for nearly half of all cases—presents a stealthier challenge. HFpEF is particularly prevalent among older women with hypertension, obesity, and diabetes, yet its symptoms are often subtle and nonspecific, mimicking conditions like pulmonary deconditioning or menopausal changes. A 2023 longitudinal study published in The Lancet followed over 15,000 participants across European cohorts and found that nearly 60% of HFpEF cases were initially misdiagnosed, with an average delay of 14 months before correct identification. This diagnostic latency directly correlates with increased morbidity: patients diagnosed late face a 2.3-fold higher risk of hospitalization and a 38% increased likelihood of cardiovascular death within two years compared to those identified early.

Funding for this pivotal research came from the European Union’s Horizon 2020 program (Grant Agreement No. 847821), with additional support from the Dutch Heart Foundation and Amsterdam UMC. The study’s lead epidemiologist, Dr. Elise van der Meer, emphasized that current screening protocols fail to capture the insidious onset of HFpEF. “We’re still relying on outdated algorithms that prioritize ejection fraction over symptomatology and comorbidities,” she noted in a recent interview. “Until we integrate BNP testing and echocardiographic strain analysis into primary care workflows for at-risk populations, we’ll keep missing the window for disease-modifying interventions.” Her comments were echoed by Professor John McMurray of the University of Glasgow, a global authority on heart failure management, who stated in a 2024 JAMA Cardiovascular review: “The real tragedy isn’t that we lack treatments—it’s that we fail to apply existing guidelines early enough. Sacubitril/valsartan, SGLT2 inhibitors, and structured exercise programs perform best when initiated before irreversible remodeling occurs.”

This gap between evidence and practice represents not just a clinical shortcoming but a systemic failure in care coordination. Primary care physicians, often the first point of contact, require better decision-support tools to differentiate burnout from early cardiac decompensation. Incorporating routine BNP testing in patients with unexplained fatigue and cardiovascular risk factors—regardless of age or gender—could significantly reduce diagnostic latency. Patient education must evolve: campaigns should explicitly warn that persistent exhaustion unrelieved by rest, especially when accompanied by orthopnea or peripheral edema, warrants cardiac evaluation—not just a vacation or mindfulness app.

For individuals experiencing unexplained exertional dyspnea, persistent fatigue, or fluid retention, timely specialist evaluation is not optional—it is a critical preventive measure. Delaying cardiology consultation increases the risk of irreversible myocardial fibrosis and reduces responsiveness to guideline-directed medical therapy. It is strongly advised to consult with vetted board-certified cardiologists who can administer advanced diagnostics such as cardiopulmonary exercise testing and cardiac MRI to detect subclinical dysfunction. Patients navigating complex diagnostic journeys may benefit from coordinated care models offered by specialized heart failure management centers, where multidisciplinary teams optimize medication titration, monitor renal function, and provide tailored rehabilitation protocols. For healthcare administrators seeking to implement BNP screening protocols in primary care networks, consulting experienced healthcare compliance attorneys ensures adherence to evolving EMA and NICE guidelines while mitigating liability risks associated with delayed diagnosis.

The trajectory of heart failure care is shifting toward earlier detection and precision phenotyping, driven by advances in artificial intelligence-assisted echocardiography and wearable hemodynamic monitors. Yet technology alone cannot close the diagnostic gap without parallel reforms in clinical awareness and access. As we enter an era where disease-modifying therapies like vericiguat and finerenone show promise even in early-stage HFpEF, the imperative grows stronger: identify the signal before the noise becomes a scream. The cost of inaction is measured not just in dollars, but in lost years of functional independence and preventable grief.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*